Baidu Announces First Quarter 2025 Results

Baidu Announces First Quarter 2025 Results

BEIJING, May 21, 2025 /PRNewswire/ -- Baidu, Inc. (NASDAQ: BIDU and HKEX: 9888 (HKD Counter) and 89888 (RMB Counter)) ("Baidu" or the "Company"), a leading AI company with a strong Internet foundation, today announced its unaudited financial results...

ZTO Reports First Quarter 2025 Unaudited Financial Results

ZTO Reports First Quarter 2025 Unaudited Financial Results

Parcels Volume Increased 19.1% to 8.5 Billion Adjusted Net Income Grew 1.6 % to RMB2.3 Billion Annual Volume Guidance Reiterated to Grow 20%-24% SHANGHAI, May 21, 2025 /PRNewswire/ -- ZTO Express (Cayman) Inc. (NYSE: ZTO and SEHK: 2057), a leading...

PeproMene Bio, Inc. and the Institute for Follicular Lymphoma Innovation (IFLI) Announce The First Follicular Lymphoma (FL) Patient Treated with BAFF-R Targeting CAR-T Cells (PMB-CT01) Achieves a Complete Response

PeproMene Bio, Inc. and the Institute for Follicular Lymphoma Innovation (IFLI) Announce The First Follicular Lymphoma (FL) Patient Treated with BAFF-R Targeting CAR-T Cells (PMB-CT01) Achieves a Complete Response

The first heavily pretreated r/r FL patient dosed at City of Hope with PMB-CT01 achieved a CR at one-month post treatment. A Total of 7/7 r/r B-NHL patients including MCL, DLBCL and FL treated with PMB-CT01 have achieved a sustained CR (1 to 29+...

NYSE Content Advisory: Pre-Market update + Home Depot reaffirms full-year outlook

NYSE Content Advisory: Pre-Market update + Home Depot reaffirms full-year outlook

NEW YORK, May 20, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. Kristen Scholer...

NYSE Content Advisory: Pre-Market update

NYSE Content Advisory: Pre-Market update

NEW YORK, May 19, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. Kristen Scholer...

Microvast at CIBF 2025: Powering What's Next

Microvast at CIBF 2025: Powering What's Next

STAFFORD, Texas, May 19, 2025 /PRNewswire/ -- Microvast Holdings, Inc. (NASDAQ: MVST) ("Microvast" or the "Company"), a global leader in advanced battery technologies, has highlighted its comprehensive suite of high-performance battery products at...

Innovent Released 2024 ESG Report, Underscoring Commitment to Sustainable Development and Global Innovation

Innovent Released 2024 ESG Report, Underscoring Commitment to Sustainable Development and Global Innovation

SAN FRANCISCO and SUZHOU, China, May 19, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of...

Advantech Collaborates with 20+ Partners for "Edge Computing & WISE-Edge in Action" Conference and Livestreamed Insight Studio Sessions at COMPUTEX 2025

Advantech Collaborates with 20+ Partners for "Edge Computing & WISE-Edge in Action" Conference and Livestreamed Insight Studio Sessions at COMPUTEX 2025

TAIPEI, May 16, 2025 /PRNewswire/ -- Advantech (TWSE: 2395), a global leader in IoT intelligent systems and embedded platforms, has announced its activities for COMPUTEX 2025 under the theme "Edge Computing & WISE-Edge in Action". Highlights...

Second Head-to-head Phase 3 Study of Mazdutide versus Semaglutide Completes First Participant Dosing in Adults in China with Overweight or Obesity Accompanied Fatty Liver Disease (GLORY-3)

Second Head-to-head Phase 3 Study of Mazdutide versus Semaglutide Completes First Participant Dosing in Adults in China with Overweight or Obesity Accompanied Fatty Liver Disease (GLORY-3)

SAN FRANCISCO and SUZHOU, China, May 16, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of...

Moatable Reports First Quarter 2025 Financial Results

Moatable Reports First Quarter 2025 Financial Results

PHOENIX, May 16, 2025 /PRNewswire/ -- Moatable, Inc. (OTC Pink: MTBLY) ("Moatable" or the "Company"), a leading US-based SaaS company, today announced financial results for its first quarter ended March 31, 2025. First Quarter 2025 Financial...

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...
  • 32
  • menu
    menu